Clicky

Biocon Limited(532523)

Description: Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Small Molecules, Biologics, Branded Formulations, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, dermatology, ophthalmology, neurology, rheumatology, and inflammatory diseases. The company provides biosimilars comprising recombinant human insulin, insulin glargine, biosimilar trastuzumab, and other biopharmaceuticals; small molecules, such as active pharmaceutical ingredients and generic formulations; and branded formulation products under the Insugen, Basalog, BIOMAb EGFR, CANMAb, and ALZUMAb brands. It is also involved in the integrated discovery, development, and manufacturing services for small and large molecules, antibody-drug conjugates, and oligonucleotides. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.


Keywords: Biotechnology Pharmaceutical Biopharmaceutical Life Sciences Diabetes Active Pharmaceutical Ingredients Inflammatory Diseases Specialty Drugs Biosimilar Recombinant Proteins Trastuzumab Insulin Glargine Botanical Products Formulation Products Biocon Medicinal Chemical Recombinant Human Insulin

Home Page: www.biocon.com

20th KM, Hosur Road
Bengaluru, 560100
India
Phone: 91 80 2808 2808


Officers

Name Title
Ms. Kiran Mazumdar-Shaw B.Sc., B.Sc (Hons) Founder & Exec. Chairperson
Mr. Siddharth Mittal MD, CEO & Director
Mr. Mayank Verma Company Sec. & Compliance Officer
Mr. Anupam Jindal Chief Financial Officer
Mr. Indranil Sen VP of Fin. & Accounts
Mr. Saurabh Paliwal Head of Investor Relations
Mr. Amitava Saha Pres of HR
Mr. Sandeep Rao M.Sc., PGDM Sr. VP
Mr. B. S. V. Prasad Chief Operating Officer of Biocon Generics & APIs
Mr. Nehal Vora Commercial Head of Biocon Global APIs & Sr. VP

Exchange: BSE

Country: IN

Currency: Indian Rupee (INR)

Forward PE: 0
Trailing PE: 73.2496
Price-to-Book MRQ: 7.5633
Price-to-Sales TTM: 7.8273
IPO Date:
Fiscal Year End: March
Full Time Employees: 12609
Back to stocks